Regarding AD, type 1 diabetes insulin deficiency seems to be the main factor for increased tau phosphorylation, while hyperglycemia-induced tau cleavage with insulin disturbances could be the factor that leads to tau pathology in type 2 diabetes [66]. This evidence concerns the gene MAPT and Hyperglycemia.